Chibnik, L B
White, C C
Mukherjee, S
Raj, T
Yu, L
Larson, E B
Montine, T J
Keene, C D
Sonnen, J
Schneider, J A
Crane, P K
Shulman, J M
Bennett, D A
De Jager, P L
Article History
Received: 6 December 2016
Accepted: 3 January 2017
First Online: 21 March 2017
Competing interests
: Dr Schneider is a consultant for Navidea Biopharmaceuticals and an advisor to Eli Lilly and Genetech. The remaining authors declare no conflict of interest.